Evidence map›Paper›PMID 38107868›Full record

ArticleFrontiers in microbiology2023

Identification of genes involved in enhanced membrane vesicle formation in

Mizuki Kanno, Takuya Shiota, So Ueno, Minato Takahara, Keisuke Haneda, Yuhei O Tahara, Masaki Shintani, Ryoma Nakao, Makoto Miyata, Kazuhide Kimbara and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Genomic Insights into Carbapenem-ResistantJournal of clinical medicine · 2026
    Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Mizuki KannoGraduate School of Science and Technology, Shizuoka University, Hamamatsu, Japan.
Takuya ShiotaDepartment of Engineering, Graduate School of Integrated Science and Technology, Shizuoka University, Hamamatsu, Japan.
So UenoDepartment of Engineering, Graduate School of Integrated Science and Technology, Shizuoka University, Hamamatsu, Japan.
Minato TakaharaDepartment of Engineering, Graduate School of Integrated Science and Technology, Shizuoka University, Hamamatsu, Japan.
Keisuke HanedaDepartment of Applied Chemistry and Biochemical Engineering, Faculty of Engineering, Shizuoka University, Hamamatsu, Japan.
Yuhei O TaharaGraduate School of Science, Osaka Metropolitan University, Osaka, Japan.
Masaki ShintaniGraduate School of Science and Technology, Shizuoka University, Hamamatsu, Japan.
Ryoma NakaoDepartment of Bacteriology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Makoto MiyataGraduate School of Science, Osaka Metropolitan University, Osaka, Japan.
Kazuhide KimbaraGraduate School of Science and Technology, Shizuoka University, Hamamatsu, Japan.
Hiroyuki FutamataGraduate School of Science and Technology, Shizuoka University, Hamamatsu, Japan.
Yosuke TashiroGraduate School of Science and Technology, Shizuoka University, Hamamatsu, Japan.
Shizuoka University · JPNational Institute of Infectious Diseases · JPOsaka Metropolitan UniversityTokyo Metropolitan University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Membrane vesicles (MVs) are small spherical structures (20-400 nm) produced by most bacteria and have important biological functions including toxin delivery, signal transfer, biofilm formation, and immunomodulation of the host. Although MV formation is enhanced in biofilms of a wide range of bacterial species, the underlying mechanisms are not fully understood. An opportunistic pathogen,

Indexed as

biofilmflagellar motilitymembrane vesiclesPseudomonas aeruginosaPsl

Identifiers

PMID38107868
PMCPMC10722149
OpenAlexW4389236067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.